ATE206929T1 - Normalisierer der blutkoagulation enthaltend tcf- ii als aktiven bestandteil - Google Patents

Normalisierer der blutkoagulation enthaltend tcf- ii als aktiven bestandteil

Info

Publication number
ATE206929T1
ATE206929T1 AT93916161T AT93916161T ATE206929T1 AT E206929 T1 ATE206929 T1 AT E206929T1 AT 93916161 T AT93916161 T AT 93916161T AT 93916161 T AT93916161 T AT 93916161T AT E206929 T1 ATE206929 T1 AT E206929T1
Authority
AT
Austria
Prior art keywords
blood coagulation
normalizer
active ingredient
containing tcf
tcf
Prior art date
Application number
AT93916161T
Other languages
English (en)
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE206929T1 publication Critical patent/ATE206929T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT93916161T 1992-07-16 1993-07-14 Normalisierer der blutkoagulation enthaltend tcf- ii als aktiven bestandteil ATE206929T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21222892 1992-07-16
JP11780993 1993-04-21
PCT/JP1993/000974 WO1994002165A1 (fr) 1992-07-16 1993-07-14 Agent de normalisation de la coagulation sanguine contenant tcf-ii comme ingredient actif

Publications (1)

Publication Number Publication Date
ATE206929T1 true ATE206929T1 (de) 2001-11-15

Family

ID=26455863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916161T ATE206929T1 (de) 1992-07-16 1993-07-14 Normalisierer der blutkoagulation enthaltend tcf- ii als aktiven bestandteil

Country Status (11)

Country Link
US (1) US5714461A (de)
EP (1) EP0653211B1 (de)
JP (1) JP3634359B2 (de)
KR (1) KR100260964B1 (de)
AT (1) ATE206929T1 (de)
AU (1) AU674871B2 (de)
CA (1) CA2140010C (de)
DE (1) DE69330960T2 (de)
DK (1) DK0653211T3 (de)
ES (1) ES2165855T3 (de)
WO (1) WO1994002165A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399744B1 (en) * 1994-12-27 2002-06-04 Daiichi Pharmaceutical Co., Ltd. TCF mutant
WO1997012628A1 (en) * 1995-10-05 1997-04-10 Genentech, Inc. Methods and compositions for treating vascular stenosis
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
AU734766B2 (en) 1997-03-14 2001-06-21 Atlas Pharmaceuticals Inc. Agent for preventing and/or treating cachexia
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
CA2549878A1 (en) 2003-12-16 2005-06-30 Toshikazu Nakamura Glycosylation-deficient hepatocyte growth factor
US7262637B2 (en) * 2005-03-22 2007-08-28 Micron Technology, Inc. Output buffer and method having a supply voltage insensitive slew rate
WO2022036366A1 (en) * 2020-08-12 2022-02-17 Figene, Llc Reduction of covid-19 coagulopathy and other inflammation-associated coagulopathies by administration of fibroblasts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076701A (en) * 1975-07-29 1978-02-28 Immunology Research Foundation, Inc. Tumor complement fraction recovery method and product
US4490549A (en) * 1977-04-19 1984-12-25 The Upjohn Company Enlarged-hetero-ring prostacyclin analogs
JPH0296598A (ja) * 1988-10-03 1990-04-09 Sapporo Breweries Ltd リンフォカイン活性化キラー細胞誘導抑制因子ｌａｋｓｆ，その製造法およびそれを有効成分とする免疫抑制剤
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
JP2634323B2 (ja) * 1990-07-13 1997-07-23 雪印乳業株式会社 Ｔｃｆ‐▲ｉｉ▼のアミノ酸配列をコードするｄｎａを含むプラスミド，形質転換細胞及びこれを用いて生理活性物質を生産する方法
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
DE69334087T2 (de) * 1992-07-16 2007-07-05 Daiichi Pharmaceutical Co., Ltd. Arzneimittelzusammensetzung enthaltend TCF-II
WO1994014845A1 (en) * 1992-12-28 1994-07-07 Snow Brand Milk Products Co., Ltd. Modified tcf
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤

Also Published As

Publication number Publication date
KR100260964B1 (ko) 2000-07-01
EP0653211A4 (de) 1996-06-26
WO1994002165A1 (fr) 1994-02-03
EP0653211A1 (de) 1995-05-17
EP0653211B1 (de) 2001-10-17
JP3634359B2 (ja) 2005-03-30
ES2165855T3 (es) 2002-04-01
KR950702433A (ko) 1995-07-29
DE69330960T2 (de) 2002-04-11
DE69330960D1 (de) 2001-11-22
AU674871B2 (en) 1997-01-16
CA2140010A1 (en) 1994-02-03
DK0653211T3 (da) 2002-05-06
AU4583393A (en) 1994-02-14
US5714461A (en) 1998-02-03
CA2140010C (en) 2008-04-01

Similar Documents

Publication Publication Date Title
ATE290867T1 (de) Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
DE3851711D1 (de) Verwendung von Morphinantagonisten zur Herstellung von Medikamenten mit immunmodulatorischer und antiviraler Wirkung, insbesondere bestimmt zur Behandlung von erworbenen Immunmangelzuständen.
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
BR9306040A (pt) Tratamento e profilaxia de doenças provocadas por parasitos ou bactérias
DE69534130D1 (de) Verbindungen zur behandlung von erkrankungen,die mit des vasculogenese und/oder angiogenese in verbunden stehen.
ES2111579T3 (es) Preparaciones de factor viii estabilizadas.
DE69427650D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DE59307717D1 (de) Fungizide Mischungen auf der Basis von Triazol-Fungiziden und 4,6-Dimethyl-N-Phenyl-2-Pyrimidinamin
ATE206929T1 (de) Normalisierer der blutkoagulation enthaltend tcf- ii als aktiven bestandteil
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE3865368D1 (de) Thiophensulfonamide zur behandlung von glaukom.
ES2093357T3 (es) Metodo de tratamiento de la alopecia.
DE69001686D1 (de) Behandlung von leukozytstoerungen mit gm-csf.
ATE136896T1 (de) Piperidylmethyl substituierte chromanderivate als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
NO932502L (no) Nye fosfolipidderivater
DK120892D0 (da) Treatment and prophylaxis of diseases caused by parasites, fungi or bacteria
DE69636814D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE69431187D1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee